Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Is your nutritional status being monitored throughout
Trulicity (dulaglutide) This once-weekly injection is approved for treating type 2 diabetes and obesity
According to CMS guidance and Medicare Rights Center analysis, the following individuals are excluded from the GLP-1 Bridge: Beneficiaries who are already receiving a GLP-1 drug through their existing Part D plan for type 2 diabetes, sleep apnea, or cardiovascular risk reduction
ITT, intent-to-treat
The pill has only been approved for adults with Type 2 diabetes who also have a cardiovascular disease or are at high risk for heart disease, though Novo Nordisk has applied to bring a separate pill form of weight loss medication Wegovy to Canada as well
US$ 22.39
US$ 24.21
US$ 23.30
US$ 24.43
